Trials / Completed
CompletedNCT01356225
A Single-dose Study of Intranasal Ketorolac in the Treatment of Pain Secondary to Dental Impaction Surgery
A Randomized, Double-blind, Placebo-controlled, Parallel, Single-dose Study of Intranasal Ketorolac in the Treatment of Pain Secondary to Dental Impaction Surgery
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Egalet Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the analgesic efficacy of a single intranasal (IN) administration of ketorolac after dental impaction surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketorolac tromethamine | 30 mg Intranasal (2 x 100 uL of a 15% solution), single dose |
| DRUG | Placebo | IN placebo |
Timeline
- Start date
- 2004-02-01
- Primary completion
- 2004-03-01
- First posted
- 2011-05-19
- Last updated
- 2017-02-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01356225. Inclusion in this directory is not an endorsement.